z-logo
Premium
Cancer in adolescents and young adults: treatment and outcome in Victoria
Author(s) -
Mitchell Anne E,
Scarcella Deborah L,
Rigutto Gemma L,
Ashley David M,
Thursfield Vicky J,
Giles Graham G,
Sexton Maree
Publication year - 2004
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2004.tb05799.x
Subject(s) - medicine , clinical trial , young adult , cancer , pediatrics , regimen , cancer treatment , incidence (geometry) , cancer registry , gerontology , surgery , physics , optics
Objectives: To describe the location of treatment, recruitment to clinical trials and outcomes for adolescents and young adults treated for cancer in Victoria. Design and setting: Retrospective review of all adolescents and young adults aged 10–24 years diagnosed with cancer between 1992 and 1996, identified from the Victorian Cancer Registry. Main outcome measures: Treatment regimen (clinical trial, treatment protocol or neither), compliance with treatment and 5‐year survival. Results: Questionnaires were completed for 576 of 665 eligible adolescents and young adults (87% response rate). Recruitment into clinical trials decreased with increasing age. Adolescents aged 10–19 years were more likely to be recruited to a clinical trial if treated at a paediatric hospital. For all cancers, 5‐year survival was similar across the age groups and was not influenced by the place of treatment. Only 1% of adolescents and young adults failed to complete planned therapy due to non‐compliance. Conclusions: Despite a similar incidence of cancer to that in younger children, adolescents and young adults with cancer are poorly recruited into clinical trials in Victoria. Establishment of a cancer resource network in Victoria may provide information to both paediatric and adult oncologists about currently available clinical trials.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here